SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,688 | +45.8% | 2,695 | +55.9% | 0.31% | +201.0% |
| Q4 2022 | $224,044 | -48.7% | 1,729 | -70.3% | 0.10% | -49.0% |
| Q2 2022 | $437,000 | -51.4% | 5,826 | -41.6% | 0.20% | -56.0% |
| Q4 2021 | $899,000 | +162.9% | 9,981 | +367.7% | 0.46% | +99.6% |
| Q2 2020 | $342,000 | +1.5% | 2,134 | -18.4% | 0.23% | +31.8% |
| Q4 2019 | $337,000 | +81.2% | 2,614 | +5.7% | 0.17% | +183.6% |
| Q3 2019 | $186,000 | – | 2,473 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |